Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 22

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 22
---
 Q: | What vote is required to approve each proposal to be considered at the Special Meeting? |

| A: | The votes required for each proposal are as follows: |

| 1. | Proposal 1—The Merger Agreement Proposal: The affirmative vote, virtually or by proxy, of                                                                                                                                   
 holders of at least a majority of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock entitled to vote on the Merger Agreement Proposal is required to approve the Merger Agreement Proposal. |

| 2. | Proposal 2—The Adjournment Proposal: The affirmative vote, virtually or by proxy, of a                                                                                                                  
 majority of the votes properly cast by holders of shares of Enfusion Common Stock and Enfusion Class B Common Stock represented at the Special Meeting is required to approve the Adjournment Proposal. |

As of March 20, 2025, the record date, Enfusion directors and executive officers, as a group, owned and were entitled to vote 46,887,683 shares of Enfusion Common Stock and Enfusion Class B Common Stock, or approximately 36.1% of the outstanding shares of Enfusion Common Stock and Enfusion Class B 8

Common Stock. Enfusion currently expects that these directors and executive officers will vote their shares in favor of the Merger Agreement Proposal and the Adjournment Proposal, although none of them are obligated to do so, other than Oleg Movchan with respect to the Merger Agreement Proposal and the Adjournment Proposal. Concurrently with the execution of the Merger Agreement, each of (i) FTV IV, L.P., (ii) FTV Investment Holdings, L.P., (iii) ICONIQ Strategic Partners V, L.P., ICONIQ Strategic Partners V-B,L.P., ISP V-BEF LP and ISP V Main Fund EF LLC and (iv) CSL Tech Holdings, LLC and Oleg Movchan (collectively, the “ Significant Stockholders”) entered into support agreements with Clearwater (the “ Support Agreements”) pursuant to which each such party agreed, among other things and subject to the terms and conditions of the Support Agreements, to vote the Enfusion Securities (as defined below) held by such party in favor of the Merger Agreement Proposal. See the section titled “The Support Agreements.” As of March 20, 2025, the record date, an aggregate of 60,267,707 shares of Enfusion Common Stock and Enfusion Class B Common Stock, or approximately